Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

MRI, Efficacy, and Safety of Tolebrutinib in Patients with Highly Active Disease (HAD): 2-Year Data from the Phase 2b Long-term Safety (LTS) Study

Author:Fox, Robert   Oh, Jiwon   Arnold, Douglas   Syed, Sana   Xu, Zhixing   Turner, Timothy   Traboulsee, Anthony   Reich, Daniel   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.017  

Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH  St Michael's Hospital, University of Toronto, Toronto, ON, Canada  NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  University of British Columbia, Vancouver, BC, Canada  National Institute of Neurological Disorders and Stroke, Bethesda, MD  

Renal function association with infarct growth rate in anterior circulation large vessel occlusion strokes

Author:Kayyali, Mohammad   Mahat, Bishow Chandra   Choi, Jessica   Song, Shlee   Rocha, Marcelo   

Session Name:P6: Cerebrovascular Disease and Interventional Neurology: Clinical Science and Systems of Care Research 1  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P6.017  

Author Institution:University of Pittsburgh Medical Centre , Pittsburgh , PA  UPMC ME, Pittsburgh, PA  Cedars-Sinai Medical Center, Los Angeles, CA  UPMC, Pittsburgh, PA